We at PhaseON have a dedicated team for conducting feasibilitiy assessment even before the start of the study. This team comprises of medical and therapeutic experts. We at PhaseOn have understood that most of the delays in study startup and patient enrollment are major contributors to cost overruns in clinical trials and that a properly designed and executed feasibility study can provide a comprehensive assessment of a clinical trial’s specific challenges as well as strategies to mitigate risks before startup activities begin.It is our experience that the companies that use feasibility studies experience have witnessed a faster clinical trial accrual and significantly fewer delays in enrollment than those that forgo this assessment.